Anti-DDAH2 antibodies are used in the immunodetection of the protein dimethylarginine dimethylaminohydrolase 2. In humans, the canonical protein has a reported length of 285 amino acid residues and a mass of 29.6 kDa. Its subcellular localization is in the mitochondria and cytoplasm. It is notably expressed in fetal placenta, lung, liver, skeletal muscle, kidney and pancreas, and at very low levels in the brain. A member of the DDAH protein family, DDAH2 is known to be involved with the regulation of apoptosis. Synonyms for this target antigen include DDAHII, G6a, HEL-S-277, NG30, N(G),N(G)-dimethylarginine dimethylaminohydrolase 2, and DDAH. DDAH2 gene orthologs have been reported in the mouse, rat, bovine, frog and chimpanzee species. A number of DDAH2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunofluorescence, and Immunohistochemistry are also common applications.